This inventor holds 3 USPTO granted patents. Top assignees: The Salk Institute, Ligand Pharmaceuticals, Inc., University of California. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 593 
1 out of 139 
1 out of 16,025 
Years Active: 1997-2000
Title: Christina S. Berger: Innovator in Hormone-Responsive Treatments
Introduction
Christina S. Berger is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medical treatments, particularly in the area of hormone-responsive diseases. With a total of 3 patents, her work focuses on innovative methods for treating conditions that respond to steroid and steroid-like hormones.
Latest Patents
One of her latest patents involves the use of selective ligands for the treatment of disease states responsive to steroid hormones. This invention provides a method for treating subjects afflicted with steroid or steroid-like hormone-responsive diseases. The method comprises administering an effective amount of a ligand that selectively interacts with the receptor subtype associated with the disease state. This ligand interacts with the receptor subtype to a significantly greater extent than with other subtypes of the same receptor class.
Another notable patent is related to non-steroidal progesterone receptor agonists and antagonists. This patent discloses high-affinity, high-specificity ligands for progesterone receptors, including synthetic derivatives of cyclocymopol and its diastereomers. The compounds are spectroscopically and chromatographically pure, with one functioning as a progesterone receptor antagonist and the other as an agonist. The patent also outlines methods for employing these compounds to modulate processes mediated by progesterone receptors.
Career Highlights
Christina has worked at esteemed institutions such as the Salk Institute and the University of California. Her research has significantly advanced the understanding of hormone interactions and their implications for treatment.
Collaborations
Throughout her career, Christina has collaborated with notable professionals in her field, including Robert B. Stein and Richard Alan Heyman. These collaborations have further enriched her research and innovations.
Conclusion
Christina S. Berger is a trailblazer in the field of hormone-responsive treatments, with a focus on innovative methods that enhance patient care. Her contributions through her patents and collaborations continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile